Pet Supplement Certifications & Parameters: A Compliance Checklist for Oral Film Sourcing

Pet Supplement Certifications & Parameters: A Compliance Checklist for Oral Film Sourcing

Buyers evaluating pet health supplements increasingly face two questions at once: does the product work, and can it be legally sold in our market? For oral dissolvable films, the answer depends on certifications, ingredient transparency, and documented specifications. This guide provides a practical compliance checklist for sourcing pet supplement oral films, using Novohope’s product family as a working example.

Why Certification and Parameter Verification Matter in Pet Supplements

Pet health supplements are not regulated in the same way as veterinary drugs, but they still require manufacturing accountability, ingredient safety documentation, and market-specific compliance. The global pet supplements market is valued at approximately USD 2.8 billion in 2025 and is projected to grow to USD 4.6 billion by 2033, according to Grand View Research. North America accounts for 48.1% of global revenue share in 2025, making US compliance documentation a priority for many importers and brand owners.

Certifications serve as evidence that a manufacturer can provide: traceability of ingredients, safety assessment under recognized standards, and consistency between what is claimed and what is delivered. Without these documents, a retailer, distributor, or e-commerce platform may reject a product during compliance review.

What Certification Documents Should a Pet Supplement Oral Film Supplier Provide?

A reliable supplier should be able to provide documentation across four categories:

• Facility registration: proof that the manufacturing site is registered with the appropriate authority for food or supplement production.
• Product safety documentation: Safety Data Sheets (SDS) and Certificates of Analysis (COA) that support safe handling and ingredient composition.
• Market-specific compliance: test reports or registrations that address the requirements of the destination country.
• Brand protection documentation: trademark filings that confirm the brand owner holds intellectual property rights in relevant classes.

Novohope, a pet health supplement brand and contract manufacturer, provides this documentation across its oral film and orally disintegrating tablet (ODT) product lines. The company focuses on oral fast-dissolving formats for pet nutrition, with products covering digestive care, eye care and tear stain management, coat and skin health, calming, joint care, cardiovascular support, and weight management.

Key Certifications for the US Market

FDA Food Facility Registration

For the US market, Novohope’s pet food and health supplements product line is registered with the U.S. Food and Drug Administration under FDA Food Facility Registration, registration number 18753066908. The registration is held by Wuxi Nuohui Biotechnology Co., Ltd and complies with Section 305 of the U.S. Public Health Security and Bioterrorism Preparedness and Response Act of 2002.

US FDA 21 CFR 175.300 Test Report for EYES+

The EYES+ Eye Care & Tear Stain Care product complies with US FDA 21 CFR 175.300, as verified by test report number DTI2026EC050626-2-2 issued by Shenzhen Deesev Testing International Corporation. This regulation relates to food-contact substances, supporting the safety profile of materials used in the product’s delivery format.

OSHA Hazard Communication Standard (HCS)

Multiple Novohope products are covered by Safety Data Sheets compliant with OSHA Hazard Communication Standard 29 CFR 1910.1200 (HCS) for the US market. For example:

• COAT+ Coat Care & shiny Hair: SDS number DTI2026EC060626-1
• EYES+ Eye Care & Tear Stain Care: SDS number DTI2026EC060626-2
• BONE+ Joint Care & Mobility Support: SDS number DTI2026EC060626-5

Global Ingredient Transparency: COA and Test Reports

Certificate of Analysis (COA) documents confirm that a product’s ingredient composition has been tested. Novohope’s products have passed SDS and COA tests, with third-party testing conducted by Shenzhen Deesev Testing International Corporation.

Two COA examples from the product line:

• COAT+ Coat Care & shiny Hair: COA number DTI2026EC050626-1, based on a customized full ingredient composition analysis test (client designated test item).
• HEART+ Cardiovascular Care: COA number DTI2026EC050626-4, based on the same customized full ingredient composition analysis test standard.

These documents are useful for brands that need to verify active ingredient presence before launching a private label product.

Understanding the Product Parameters Behind the Certifications

Certifications confirm compliance, but parameters define the product. When evaluating pet supplement oral films, buyers should examine the following specifications:

This level of specificity matters because it allows a buyer to compare products across suppliers without relying on marketing language.

Comparing Oral Dissolvable Films with Traditional Pet Supplement Formats

Oral dissolvable film technology is emerging in the pet sector, with industry innovations focusing on disintegration times below 25 seconds and taste-masking palatability improvements of up to 47%, according to Market Reports World.

Novohope’s oral film format is designed to dissolve within 10 seconds of contact with pet saliva. The active ingredients are absorbed directly through the oral mucosa into the bloodstream, bypassing the gastrointestinal tract and avoiding degradation from stomach acid and digestive enzymes. The company states that this mucosal absorption approach can reach approximately 95% absorption efficiency, compared with roughly 35% for traditional supplement formats.

Traditional powders and tablets come with three common challenges:

• Feeding difficulty: pets may refuse food, hide medicine, or spit out tablets.
• Unstable absorption: digestive conditions strongly affect how much active ingredient reaches the bloodstream.
• Dosage uncertainty: mixing powder into food makes it difficult to guarantee intake.

The oral film format addresses these points through dissolution speed, mucosal absorption, and single-film dosage precision.

How to Use Certifications as a Supplier Evaluation Framework

Below is a supplier evaluation checklist that buyers can apply when reviewing any pet supplement oral film manufacturer:

1. Confirm the target market first. US, EU, and Asia-Pacific markets have different documentation expectations. US-focused brands should prioritize FDA registration and SDS documentation.
2. Request FDA Food Facility Registration. Verify the registration number and the legal entity name on the certificate.
3. Request SDS for each SKU. An SDS confirms hazard communication compliance under the applicable standard, such as OSHA HCS 29 CFR 1910.1200.
4. Request COA for each formula. A COA should confirm active ingredient composition and match the product label.
5. Check market-specific test reports. For example, US FDA 21 CFR 175.300 compliance may be relevant for products with specific packaging or material considerations.
6. Verify the dosage form and specification. Confirm whether the product is an ODF or ODT, and check net weight, tablet count, and ingredient amounts.
7. Ask about brand protection. If you are building a private label, confirm that the manufacturer or brand owner holds relevant trademark rights.

Use Cases: Who Needs Certification Documentation?

Private Label Brands Entering North America

For a brand launching pet supplement oral films in the US, FDA facility registration and SDS documentation are the baseline. A test report confirming compliance with US FDA 21 CFR 175.300 for a tear stain formula can serve as additional evidence during retailer compliance review.

Retailers and Distributors Auditing Suppliers

Retail buyers often require suppliers to provide COA documents for each batch or formula. The availability of COA documentation for products such as HEART+ Cardiovascular Care and COAT+ Coat Care & shiny Hair demonstrates that the manufacturer has a documented ingredient verification process.

ODM Buyers Developing Custom Formulas

Buyers who want to create custom formulations should check whether the manufacturer can provide documentation for base formulas before modification. This helps separate regulatory risk from formula development work.

Manufacturing and ODM Capabilities That Support Compliance

Compliance documentation is easier to maintain when the manufacturer has established production systems. Novohope’s production capabilities include:

• Production modes: brand agency, distribution, OEM and ODM
• Customization: recipe, brand, packaging design, and other customized requirements
• Monthly capacity: 200,000,000 units
• Lead time: 35–45 days
• MOQ: 3,000 units per SKU
• Quality control: 100% full inspection before delivery plus third-party authoritative sampling testing
• Export markets: Europe, North America, Southeast Asia, Middle East, East Asia
• After-sales support: remote support

These manufacturing parameters are directly relevant to a buyer’s compliance timeline. If the target launch date depends on documentation review, a supplier’s lead time and quality control process should be verified before contract signing.

FAQ

Conclusion

Pet supplement certifications and parameters are not just administrative paperwork. They are the foundation of market access, retailer acceptance, and consumer trust. For oral dissolvable film products, buyers should verify FDA registration, SDS and COA documentation, market-specific test reports, and the exact product specifications before committing to a supplier.

Novohope provides a documented example of how an oral film manufacturer can support compliance across US and global markets, with a product family that includes tear stain care, coat care, calming, joint care, cardiovascular support, digestive care, and weight management. If you are evaluating a supplier for private label or ODM production, certification documents should be at the top of your checklist.